The PAX3-FOXO1 oncoprotein in alveolar rhabdomyosarcoma (ARMS) is presented as a paradigm to examine therapeutic strategies for targeting sarcoma-associated fusion genes.     ///    This review discusses the role of PAX3-FOXO1 in ARMS tumors.     ///    "Besides evaluating various approaches to molecularly target PAX3-FOXO1 itself, this review highlights therapeutically attractive downstream genes activated by PAX3-FOXO1. "    ///    A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma.. 